RPCEC00000281尚未招募2 期
Evaluation of the effect of the nutritional supplement Oncoxin®-Viusid® on the quality of life of patients with advanced pancreatic adenocarcinoma. Phase II.
aboratories Catalysis, S.A0 个研究点目标入组 30 人开始时间: 2018年8月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment
入排标准
- 年龄范围
- 18 years 至 one（—）
- 性别
- All
入选标准
- •1- Patients of any sex, resident in Cuba, with an age greater than or equal to 18 years.
- •2- Patients that meet the diagnostic criteria.
- •3- Patients with general health according to Karnofsky =70%.
- •4- Life expectancy greater than or equal to 3 months.
- •5- Patients eligible to receive chemotherapy.
- •6- Patients who have signed the informed consent.
- •7- Patients who have laboratory values in parameters that do not contraindicate the administration of chemotherapy: Hemoglobin = 90 g/l, Total Leukocyte Count = 3.0 x 109 / L, Absolute Neutrophil Count =1.5 x 109 / L. o Platelet count =100 x 109 / L, Total bilirubin values = 1.5 times the upper limit of the normal range established in the institution, TGO and TGP values =2.5 times the upper limit of the normal interval established in the institution and, Creatinine values within the normal limits of the institution.
排除标准
- •1- Patients who are receiving another product under investigation.
- •2- Patients with known hypersensitivity to any of the active ingredients of the chemotherapy used
- •3- Patients with decompensated intercurrent diseases, including: HBP, Diabetes Mellitus, Ischemic Heart Disease, active infections, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, liver damage or any other special condition that at the discretion of the doctor puts their health at risk and his life during the study or his participation in the trial.
- •4-Patients who are pregnant or breastfeeding.
- •5- Patients with mental disorders that could limit adherence to the requirements of the clinical trial and may hinder the collection of information, treatment or follow-up.
- •6- Patients with brain metastases.
研究者
相似试验
尚未招募
2 期
Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase IIColorectal NeoplasmsMetastatic colorectal adenocarcinomaIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsRectal DiseasesColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesRPCEC00000276Catalysis S40
已完成
不适用
Effect of a nutritional supplement on attention and mood in adults with Attention-Deficit/Hyperactivity Disorder (ADHD)Attention-Deficit/Hyperactivity DisorderMood instabilityMental Health - Other mental health disordersMental Health - DepressionACTRN12609000308291Julia Rucklidge80
已完成
不适用
utritional supplements and withdrawal symptoms in smoking cessation.ACTRN12613001188729niversity of Canterbury24
已完成
不适用
A randomized controlled trial investigating the efficacy and safety of a micronutrient formula in the treatment of Attention-Deficit/Hyperactivity Disorder in childreADHDAlternative and Complementary Medicine - Other alternative and complementary medicineMental Health - Other mental health disordersACTRN12613000896774niversity of Canterbury93
已完成
1 期
Effect of a nutritional supplement on attention and mood in adults with Attention-Deficit/Hyperactivity DisorderAttention-Deficit/Hyperactivity DisorderMood instabilityMental Health - Other mental health disordersMental Health - DepressionACTRN12609000202268Julia Rucklidge15